Mesoblast acquires remaining 67% stake in Angioblast Systems - MarketLine Financial Deals

Mesoblast acquires remaining 67% stake in Angioblast Systems

Mesoblast acquires remaining 67% stake in Angioblast Systems - MarketLine Financial Deals
Mesoblast acquires remaining 67% stake in Angioblast Systems
Published Dec 23, 2010
3 pages — Published Dec 23, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Mesoblast Limited, an Australia-based biotechnology company, has acquired the remaining 67% interest in Angioblast Systems, Inc. with the issue of 90.8 million ordinary shares to former Angioblast security holders, increasing the total number of shares on offer to 253.8 million shares. Notably, no former Angioblast security holders elected to take a cash entitlement, resulting in a total saving to Mesoblast of approximately $47 million.

  
Source:
Document ID
MA25005_100517
Country
Country
Ticker
MSB=AU
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Mesoblast acquires remaining 67% stake in Angioblast Systems" Dec 23, 2010. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Mesoblast-acquires-remaining-67-stake-in-Angioblast-Systems-2052-32945>
  
APA:
MarketLine Financial Deals. (2010). Mesoblast acquires remaining 67% stake in Angioblast Systems Dec 23, 2010. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Mesoblast-acquires-remaining-67-stake-in-Angioblast-Systems-2052-32945>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.